Clinical Trial Update: Bioequivalence Study to Compare Empagliflozin + Linagliptin 25 mg/5 mg Film-coated Tablets Versus Glyxambi 25 mg/ 5 mg Film-coated Tablets [Phase 1]

View source ↗

Summary

Phase 1 bioequivalence study comparing empagliflozin + linagliptin 25 mg/5 mg film-coated tablets to Glyxambi 25 mg/5 mg film-coated tablets in adults with Type…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Empagliflozin + Linagliptin 25 mg/5 mg Film-coated Tablets (empagliflozin/linagliptin)
• Glyxambi 25 mg/5 mg Film-coated Tablets (empagliflozin/linagliptin)

Snippet

Sponsor: Humanis Saglık Anonim Sirketi | Conditions: Type 2 Diabetes Mellitus (T2DM) | Phase 1 | Status: COMPLETED